510714-32-6

Basic information

• Product Name: (2S)-4-methyl-2-{[(3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino}pentanoic acid ethyl ester
• Synonyms: (2S)-4-methyl-2-{[(3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino}pentanoic acid ethyl ester
• CAS NO: 510714-32-6
• Molecular Weight: 442.601
• Mol File: 510714-32-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (2S)-4-methyl-2-{[(3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino}pentanoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-4-methyl-2-{[(3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino}pentanoic acid ethyl ester(510714-32-6)
• EPA Substance Registry System: (2S)-4-methyl-2-{[(3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino}pentanoic acid ethyl ester(510714-32-6)

Safety Data

• Hazardous Substances Data: 510714-32-6(Hazardous Substances Data)

Upstream product

• 220605-36-7 (3R)-4-(toluene-4-sulfonyl)thiomorpholine-3-carboxylic acid 
• 2743-40-0 L-leucine ethyl ester hydrochloride 
• 73913-65-2 D-(-)-leucine ethyl ester hydrochloride 
• 56674-34-1 (R)-2-amino-3-<(2-chloroethyl)sulfanyl>propanoic acid hydrochloride 
• 6367-98-2 (-)-(2R)-2-amino-3-(2-hydroxyethylsulfanyl)propanoic acid 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 532984-31-9 2-{[(3R)-1,1-dioxo-4-(4-toluenesulfonyl)thiomorpholine-3-carbonyl]amino}-4-methyl-pentanoic acid ethyl ester 

Relevant articles and documents

Thiazine amide derivative thereof in the preparation of medicaments for preventing neurodegenerative diseases, the use of the

The invention relates to a compound shown as the formula I, pharmaceutically acceptable salts of the compound, and/ or solvates and/ or hydrates of the compound. The invention also relates to a preparation method of the compound, a medicinal composition c

Thiazine Amide Derivative and Pharmaceutical Composition and Use Thereof

The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hy